Strut Health's injection page displays a $119 starting offer and an automatic-refill label. It also links to oral sermorelin. Those details call for a precise comparison: the product route, supplied quantity, and refill terms matter just as much as the number on the page.

This Second Look review examines the public offer and the full financial commitment. CoreAge Rx is this publication’s featured commercial partner and appears first in our shortlists. That placement does not establish that another provider is clinically inferior. We reviewed public material; we have not purchased treatment, audited the pharmacy, or collected comparable patient outcome data.

Keep this in mind

Strut may be useful to compare when a reader wants visible safety information and clarity about alternative formats. The first task is making sure the selected offer corresponds to the intended prescription.

A route-specific review of the injection offer

We recorded the $119 figure as a starting offer, not a verified all-in monthly cost for every patient. Final pricing and the prescription depend on consultation. Ask how much medicine is supplied, what period the quote is intended to cover, when the next charge occurs, and whether a prescription adjustment changes that amount. The provider's own page is the source of the advertised terms recorded here, checked September 21, 2026. Offers can change after that date.

Published offer: Starting at $119. Injection page starting offer; confirm supply period, refill interval, and final pricing. Use our cost guide to distinguish an introductory figure from an ongoing commitment. A promotional starting price should never stand in for the complete amount you authorize.

What the service description tells us

Strut publishes a substantial safety section alongside its product information. It raises issues including tumor history, diabetes or glucose concerns, thyroid conditions, pregnancy, and other growth-hormone-related medicines. That visibility helps a reader prepare a medical history. It is not an exhaustive individual screening tool, and the company's eligibility policies should be clarified with its clinician. The public description gives a starting point for questions; it does not establish a measured standard of care. State availability, clinician eligibility decisions, pharmacy assignment, and the final prescription should be confirmed for your own situation.

A useful review follows responsibility through the whole process. Ask for the prescribing practice's name, the clinician responsible for follow-up, and the dispensing pharmacy's contact details. The pharmacy checklist explains why those organizations may be different from the name on the website.

The claim that deserves a second look

The page contains both general directions and statements about more than one delivery format. A reader should follow the directions on their own prescription, not copy a website schedule or another patient's syringe markings. If a label differs from the public page, the prescribing clinician and dispensing pharmacist should resolve the discrepancy before use. The Endocrine Society's guidance on adult growth hormone deficiency concerns a defined diagnosis. It should not be taken as an endorsement of sermorelin for every person experiencing normal aging.

Our benefits and evidence guide separates studies of the exact drug from research about a related hormone pathway. Ask which findings apply to the proposed formulation and your intended outcome. A laboratory change and a meaningful improvement in everyday life are different claims.

A conversation to have before paying

Start with this provider-specific question: Which route and quantity does this offer cover, and what exactly triggers an automatic refill and charge? Request the answer in writing along with the selected product, the first charge, and the renewal date. If a detail is not available on the sales page, treat it as unresolved rather than assuming it is included or free.

Then discuss why treatment is being considered. Describe the problem in practical terms, such as when tiredness occurs or how sleep has changed, and provide your complete health history. Our consultation questions cover alternatives, monitoring, and what happens when a clinician decides not to prescribe.

Safety, pharmacy, and follow-up

Compounded sermorelin is not FDA-approved. The FDA explains that compounded preparations do not undergo its premarket review for safety, effectiveness, and quality. That distinction applies to Strut Health and to our featured partner alike.

Discuss allergies, tumor or cancer history, pituitary or other endocrine conditions, glucose concerns, pregnancy or breastfeeding where relevant, and all medicines and supplements. The side-effect guide provides general context, but the prescriber must assess your circumstances. Severe reactions such as difficulty breathing or face or throat swelling require emergency care.

If a prescription is issued, ask the pharmacist to reconcile the concentration, prescribed amount, supplied device, storage directions, and beyond-use date. Never copy another person's syringe markings. Ask how to obtain help with a damaged or delayed shipment and which medical contact is available after the initial visit.

Who may find this option worth investigating

Strut may be useful to compare when a reader wants visible safety information and clarity about alternative formats. The first task is making sure the selected offer corresponds to the intended prescription. We would pause the purchasing decision if the exact preparation, medical follow-up, or recurring bill remained unclear. Those are answerable questions, not reasons to substitute an unsupported star rating.

Before making a shortlist, compare the other reviewed services and the online-provider comparison. Keep a copy of the offer and the answers you received. A sound decision can end with a different service, further evaluation, or no treatment; the point is to understand the choice before making the commitment.

The source notes

Sources & further reading

Provider pages document advertised offers, not independently proven outcomes. Historical references may concern different products or uses. Sources were checked for this edition on September 21, 2026; offers can change.

  1. Strut Health: reviewed product or program page
  2. Strut Health: supporting information
  3. FDA: Compounding and FDA questions and answers
  4. Endocrine Society: Adult growth hormone deficiency guideline